SCHEMBL20766880

SCHEMBL20766880

CC(C)COc1ccc(CN(Cc2ccc(F)cc2F)C(=O)NC2CCNCC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 18/20 0.65
SLC6A2 P23975 3/20 0.46
SLC6A3 Q01959 3/20 0.46
SLC6A4 P31645 2/20 0.46
ABCB11 O95342 1/20 0.45
CYP1A2 P05177 1/20 0.45
ADRB2 P07550 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM1 P11229 1/20 0.45
DRD1 P21728 1/20 0.45
TBXA2R P21731 1/20 0.45
HTR2C P28335 1/20 0.45
GPR183 P32249 1/20 0.45
CYP2C19 P33261 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRM1 P35372 1/20 0.45
APLNR P35414 1/20 0.45
DRD3 P35462 1/20 0.45
CX3CR1 P49238 1/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766381 0.91 HTR2A (0.63) HTR2ASLC6A2SLC6A3SLC6A4ABCB11
SCHEMBL20766247 0.89 HTR2A (0.62) HTR2ASLC6A2SLC6A3SLC6A4
SCHEMBL20766509 0.89 HTR2A (0.83) HTR2ASLC6A2SLC6A3ABCB11CYP1A2
SCHEMBL20766430 0.89 HTR2A (0.49) HTR2ASLC6A2SLC6A3SLC6A4
SCHEMBL20766388 0.89 HTR2A (0.52) HTR2ASLC6A2SLC6A3SLC6A4
SCHEMBL20766347 0.88 ALDH1A1 (0.52) HTR2ASLC6A2SLC6A3SLC6A4CHRM2
SCHEMBL20766412 0.86 HTR2A (0.50) HTR2ASLC6A2SLC6A3SLC6A4HRH3
SCHEMBL20766263 0.85 HTR2A (0.71) HTR2ASLC6A2SLC6A3ABCB11CYP1A2
SCHEMBL20766028 0.85 HTR2A (0.71) HTR2ASLC6A2SLC6A3ABCB11CYP1A2
SCHEMBL20766382 0.84 HTR2A (0.55) HTR2ASLC6A2SLC6A3SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672954-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES Acadia Pharmaceuticals Inc. (US) 2020-07-01 EP claimed
WO-2019040107-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO claimed
EP-3672954-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES Acadia Pharmaceuticals Inc. (US) 2020-07-01 EP disclosed
WO-2019040107-A1 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed